We focus on long-term partnerships with original equipment manufacturers (OEMs), supporting their expansion across Asia through equity participants, joint ventures, and regional holding structures.
Acraxis is not a short-term distributor. We are a platform builder committed to sustainable regional growth.
Acraxis is a coined name formed from “Acr” and “Axis.”
Acr evokes across, acre, accurate, and acumen, reflecting regional breadth, structural solidity, disciplined precision, and strategic insight across markets.
Axis represents a central line of alignment and rotation—signifying stability, coordination, and a hub around which growth occurs.
Together, Acraxis conveys the idea of a strategic axis connecting opportunities across Asia-Pacific, acting as a central platform that aligns capital, technology, and regional expertise.
As a Hong Kong–incorporated investment holding company, Acraxis embodies:
A regional anchor for medical technology businesses
Cross-market integration between innovators, OEMs, and local partners
A long-term, execution-driven platform enabling scalable and sustainable growth in Asia-Pacific
In essence, Acraxis is the axis through which medical technology investments move, align, and scale across the region.